Quantcast

International Isotopes Inc. Uranium De-Conversion and Fluorine Extraction Plant Slated for Hobbs, NM Gets Strong Local Support at Recent U.S. Nuclear Regulatory Commission Meeting

February 2, 2010

IDAHO FALLS, Idaho, Feb. 2 /PRNewswire-FirstCall/ — International Isotopes Inc. (OTC Bulletin Board: INIS) announces its planned uranium de-conversion and flourine extraction plant received overwhelming local support at a recent U.S. Nuclear Regulatory Commission (NRC) meeting held in Hobbs, New Mexico.

Steve T. Laflin, President and CEO of International Isotopes Inc. said, “We are extremely gratified with the Hobbs, New Mexico and Lea County support for our proposed uranium de-conversion and fluorine gas extraction plant. At a recent U.S. Nuclear Regulatory Commission meeting held in Hobbs, we had over 85 community leaders and residents in attendance including Lea County Commission Chairman, Gary Schubert and Hobbs Mayor Gary Don Reagan. Mr. Schubert presented the NRC a letter of support signed by the entire county commission. Community leaders from the county, Hobbs, Eunice and Lovington, New Mexico, as well as state representatives all spoke in support of our proposed facility. There were no comments against the project.

“We plan to build the most technologically advanced, safe and environmentally-friendly depleted uranium de-conversion and fluorine extraction facility in the nation. Our estimated $93 million facility will use the Company’s patented fluorine extraction process technology to convert byproduct materials from uranium enrichment operations into readily disposable forms, and in the process, produce high-value, specialty fluoride gases, which are used to make important products such as organic complexes, photovoltaic materials, and used in ion implant processes. Our long term goal remains the same – to improve and grow shareholder value,” concluded Laflin.

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including the statements with respect to state or local support for the project and plans to build the uranium de-conversion and fluorine extraction facility. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of International Isotopes Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes Inc.’s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-K for the year ending December 31, 2008. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Additional factors that could materially affect the results, performance or achievements of the Company include the ability to successfully obtain additional funding necessary to complete its planned de-conversion facility. Achievement by the Company of the project is substantially dependent on success in securing off-take agreements with commercial enrichment companies for depleted uranium hexafluoride for de-conversion services and supply of the raw material for the production of high quality fluoride gasses. The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


    FOR MORE INFORMATION CONTACT:

    Jim Drewitz
    Creative Options Communications
    Investor & Public Relations
    jim@jdcreativeoptions.com
    Phone: 830-669-2466

For more information, please visit the Company web site www.intisoid.com

SOURCE International Isotopes Inc.


Source: newswire



comments powered by Disqus